Thrombotic thrombocytopenic purpura with juvenile systemic lupus erythematosus: successful treatment with caplacizumab and rituximab

被引：0
作者：
Tadafumi Yokoyama [1 ]
Takuya Mimura [1 ]
Hiroki Tanaka [1 ]
Ria Kasahara [2 ]
Masaaki Usami [1 ]
Yusuke Matsuda [1 ]
Toshihiro Fujiki [1 ]
Taizo Wada [1 ]
机构：
[1] Kanazawa University Hospital,Department of Pediatrics
[2] National Hospital Organization,Department of Pediatrics
[3] Kanazawa Medical Center,undefined
来源：
Pediatric Rheumatology | / 22卷 / 1期
关键词：
Thrombotic thrombocytopenic purpura; Systemic lupus erythematosus; ADAMTS13 inhibitor; Caplacizumab; Rituximab;
D O I：
10.1186/s12969-024-01049-0
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Caplacizumab for relapsing thrombotic thrombocytopenic purpura
    Veronika Kaczmarek
    Johannes Holle
    Rebekka Astudillo
    Caroline Kempf
    Philip Bufler
    Dominik Müller
    Pediatric Nephrology, 2019, 34 : 1625 - 1628
  • [32] Successful use of a second course of caplacizumab in relapsed thrombotic thrombocytopenic purpura
    Shaffer, Jon
    Grove, Angela
    PLATELETS, 2022, 33 (05) : 790 - 791
  • [33] Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab
    Chemnitz, J
    Draube, A
    Scheid, C
    Staib, P
    Schulz, A
    Diehl, V
    Söhngen, D
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 71 (02) : 105 - 108
  • [34] Systemic Lupus Erythematosus Presenting With Thrombotic Thrombocytopenic Purpura at Onset: A Case Report
    Takagi, Yoko
    Kobayashi, Yasuko
    Hirakata, Ayako
    Takei, Mariko
    Ogasawara, Satoshi
    Yajima, Chikage
    Ikeuchi, Yuka
    Matsumoto, Akira
    Ogawa, Yoshiyuki
    Handa, Hiroshi
    Matsumoto, Masanori
    Arakawa, Hirokazu
    Takizawa, Takumi
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [35] A critical evaluation of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura
    Gomez-Segui, Ines
    Fernandez-Zarzoso, Miguel
    de la Rubia, Javier
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (11) : 1153 - 1164
  • [36] Early response to caplacizumab and rituximab after anaphylaxis to Octaplas plasma in a patient with thrombotic thrombocytopenic purpura
    Perrone, Salvatore
    Passucci, Mauro
    La Barbera, Elettra Ortu
    Capriata, Marcello
    Ferretti, Antonietta
    Mecozzi, Alessandra
    Giovangrossi, Piera
    Equitani, Francesco
    Cimino, Giuseppe
    JOURNAL OF CLINICAL APHERESIS, 2021, 36 (03) : 499 - 504
  • [37] Fatal Refractory Thrombotic Thrombocytopenic Purpura Complicating Systemic Lupus Erythematosus
    Tselios, Konstantinos
    Klonizakis, Philippos
    Sarantopoulos, Alexandros
    Gkougkourelas, Ioannis
    Boura, Panagiota
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2013, 19 (07) : 412 - 414
  • [38] Use of cyclophosphamide in the treatment of thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus:: report of two cases
    Pérez-Sánchez, I
    Anguita, J
    Pintado, T
    ANNALS OF HEMATOLOGY, 1999, 78 (06) : 285 - 287
  • [39] Successful treatment of thrombotic thrombocytopenic purpura with plasmapheresis and anti-CD20 antibodies in a patient with immune thrombocytopenia and systemic lupus erythematosus Case report
    Jung, Ju-Yang
    Kim, Ji-Won
    Suh, Chang-Hee
    Kim, Hyoun-Ah
    MEDICINE, 2022, 101 (07) : E28908
  • [40] Rituximab in the treatment of relapsed thrombotic thrombocytopenic purpura
    Pavan S. Reddy
    Delva Deauna-Limayo
    James D. Cook
    Siddhartha S. Ganguly
    Carol Blecke
    David C. Bodensteiner
    Barry S. Skikne
    Mervin A. Sahud
    Annals of Hematology, 2005, 84 : 232 - 235
12345